Preview Mode Links will not work in preview mode

May 21, 2019

Will the automated expansion of organoids help improve the productivity of cancer drug discovery?

Increasingly, complex cell-based assays and tissues are routinely used as part of cancer drug discovery. However, conventional monolayer or suspension cultures can be poorly predictive of the relevant therapeutic effects on...


May 7, 2019

Changing demands in global healthcare over the past 15 years have led to greater complexity and spiralling costs in drug development. The average price tag of taking a new drug from discovery to completion of Phase III clinical trials is now $2.87 billion (1), which means informed decisions need to be made early on...